Floatz logo

MACROGOLS

Diverticulitis

Thomas Jefferson UniversitymixtureEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Diverticulitis cohort.

Asset / SponsorPhaseRating
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Des Moines University
Phase 4BBB
Hextend
Corewell Health West
Phase 3BB
LIDOCAINE
Franco Carli
Phase 2B
NEPENTHE
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 1/2CCC
METRONIDAZOLE
Thomas Jefferson University
Early Phase 1C
NEOMYCIN
Thomas Jefferson University
Early Phase 1C
CAFFEINE
Thomas Steffen
N/AD

Same molecule, other indications

MACROGOLS is also rated in:

inflammatory bowel diseaseDormant
A
Indicative ·
81 / 100
View asset →
polyp of colonDormant
BBB
Indicative ·
75 / 100
View asset →
Surgical Site InfectionDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →